| Literature DB >> 25004803 |
Andrea Gaggioli1, Federica Pallavicini, Luca Morganti, Silvia Serino, Chiara Scaratti, Marilena Briguglio, Giulia Crifaci, Noemi Vetrano, Annunziata Giulintano, Giuseppe Bernava, Gennaro Tartarisco, Giovanni Pioggia, Simona Raspelli, Pietro Cipresso, Cinzia Vigna, Alessandra Grassi, Margherita Baruffi, Brenda Wiederhold, Giuseppe Riva.
Abstract
BACKGROUND: The recent convergence between technology and medicine is offering innovative methods and tools for behavioral health care. Among these, an emerging approach is the use of virtual reality (VR) within exposure-based protocols for anxiety disorders, and in particular posttraumatic stress disorder. However, no systematically tested VR protocols are available for the management of psychological stress.Entities:
Keywords: Interreality; biofeedback training; biosensors; heart rate; heart rate variability; physiological monitoring; psychological stress; relaxation training; smartphones; virtual reality
Mesh:
Year: 2014 PMID: 25004803 PMCID: PMC4115267 DOI: 10.2196/jmir.3235
Source DB: PubMed Journal: J Med Internet Res ISSN: 1438-8871 Impact factor: 5.428
Figure 1Advantages of Interreality.
Figure 2The Interreality paradigm for the management of psychological stress.
Figure 3Consort flowchart.
Demographic parameters and baseline characteristics of the sample (mean and standard deviation).
| Variables | EG | CG | W-L | |
| Age |
| 46.3 (7.7) | 42.9 (10.5) | 39.6 (9.7) |
| Years of education |
| 17.9 (1.4) | 17.3 (1.4) | 18.3 (1.3) |
| PSMa |
| 91.4 (25.8) | 86 (19.5) | 92.6 (25.8) |
| PSSb |
| 21.1 (7.9) | 18 (5.9) | 19.4 (6.6) |
| STAI-Y2c |
| 43.6 (11.2) | 42.1 (11.1) | 40.2 (9.8) |
| SWLSd |
| 23.4 (6.2) | 24.2 (7.2) | 26.4 (7.0) |
|
|
|
|
|
|
|
| Use of emotional support | 27.8 (8.2) | 29.9 (7.0) | 29.4 (7.7) |
|
| Positive attitude | 27.9 (5.5) | 29.1 (5.1) | 31.8 (4.5) |
|
| Problem focused | 28.6 (6.0) | 29.2 (7.4) | 31.7 (4.6) |
|
| Religious coping | 19.8 (5.0) | 21.7 (5.4) | 23.8 (5.5) |
|
| Denial | 24.1 (5.9) | 21.8 (4.7) | 22.8 (3.8) |
aPsychological Stress Measure.
bPerceived Stress Scale.
cState-Trait Anxiety Inventory Form Y-2.
dSatisfaction With Life Scale.
eCoping Orientation to the Problems Experienced—New Italian Version.
Figure 4Technologies used by the experimental group.
The different virtual stressful scenarios.
| Virtual scenarios for teachers | Virtual scenarios for nurses |
| Workload | Managing the patients’ relatives |
| Class management | Managing patients’ complaints |
| Coping with parent’s criticism | Managing a medical emergency situation |
| Relationship with boss | Relationship with colleagues |
| Coping with parents’ handling efforts | Managing relatives’/caregivers anxiety |
| Relationship with co-workers | Distribution of work tasks |
| Conflict management | Patient-doctor communication |
|
| Managing patient’s anxiety |
|
| Unsuccessful collaboration/communication with colleagues |
|
| Discussions among medical doctors |
Figure 5A Virtual Reality treatment session of the Interreality trial.
ANCOVA results.
| Variables | Group | ANCOVA | |||||||
| Experimental | Control | Waiting List |
| df |
|
| |||
|
| |||||||||
|
|
| Time 1 | 43.6 (11.2) | 42.1 (11.1) | 39.8 (8.71) | 4.42 | 2, 107 | .014 | .74 |
|
|
| Time 2 | 38.2 (8.09) | 41.8 (10.8) | 40.2 (8.82) | ||||
|
| |||||||||
|
| Use of emotional support |
|
|
|
|
|
|
|
|
|
|
| Time 1 | 27.8 (8.23) | 29.9 (7.04) | 29.4 (7.17) | 17.2 | 2, 111 | <.001 | .237 |
|
|
| Time 2 | 31.7 (7.62) | 29.5 (6.82) | 28.8 (7.59) | ||||
|
| Positive attitude |
|
|
|
|
|
|
|
|
|
|
| Time 1 | 27.9 (5.54) | 29.1 (4.69) | 31.7 (4.08) | 16.7 | 2, 109 | <.001 | .234 |
|
|
| Time 2 | 31.4 (5.16) | 29.4 (5.86) | 30.9 (4.01) | ||||
|
| Problem focused |
|
|
|
|
|
|
|
|
|
|
| Time 1 | 28.6 (5.96) | 29.2 (7.36) | 31.3 (3.78) | 6.34 | 2, 109 | .002 | .104 |
|
|
| Time 2 | 31.7 (7.62) | 29.5 (6.48) | 29.6 (6.02) | ||||
|
| Religious coping |
|
|
|
|
|
|
|
|
|
|
| Time 1 | 19.8 (5.01) | 21.7 (5.39) | 23.8 (5.63) | 2.81 | 2, 111 | .064 | .048 |
|
|
| Time 2 | 21.1 (6.65) | 21.3 (5.63) | 23.2 (6.1) | ||||
|
| Denial |
|
|
|
|
|
|
|
|
|
|
| Time 1 | 24.1 (5.91) | 21.8 (4.69) | 23.1 (3.69) | 18.6 | 2, 116 | .009 | .082 |
|
|
| Time 2 | 22.3 (5.13) | 20.9 (4.28) | 24 (5.27) | ||||
|
| |||||||||
|
|
| Time 1 | 21.1 (7.95) | 18 (5.94) | 19.5 (6.64) | 10.1 | 2, 111 | <.001 | .155 |
|
|
| Time 2 | 16. 6 (4.75) | 15 (5.55) | 19.8 (7.24) | ||||
|
| |||||||||
|
|
| Time 1 | 91.4 (25.8) | 86.1 (19.5) | 92.3 (26.1) | 2.2 | 2, 111 | .115 | .39 |
|
|
| Time 2 | 79.2 (18.3) | 81.6 (19.8) | 92.4 (23.2) | ||||
|
| |||||||||
|
|
| Time 1 | 23.4 (6.22) | 24.2 (7.18) | 26.5 (6.95) | 3.43 | 2, 111 | .036 | .058 |
|
|
| Time 2 | 25.5 (6.57) | 24.5 (7.53) | 23.2 (6.1) | ||||
Figure 6Mean VAS-A reduction (pre-post) in the 8 treatment sessions for both treatment groups.